Drug intelligence / Profile preview

REDIPEG

Development stage
Unknown
Lead developer
Aurora Biofarma
Modality
Small Molecules
Administration
Oral
01

Overview

REDIPEG is a medical device (classified as CE 0426) developed by the Italian pharmaceutical company Aurora Biofarma for the treatment of chronic constipation and associated gastrointestinal symptoms such as bloating and excessive gas production. The product is a combination of Macrogol 4000 (polyethylene glycol 4000) and Simeticone. Macrogol 4000 functions as an osmotic laxative, attracting water into the intestinal lumen to soften stools and increase their volume, thereby facilitating evacuation without causing cramping or mucosal irritation. Simeticone acts as an anti-foaming agent that reduces the surface tension of gas bubbles in the digestive tract, aiding in their absorption or elimination. REDIPEG is formulated as ready-to-drink orange-flavored stick packs and is indicated for use in both adults and children from one year of age.

Brand names
REDIPEG

Beyond the preview

Go deeper on REDIPEG.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on REDIPEG.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call